1. "2020"
Formats
  1. Journal Article (2337)
  2. Meeting Abstract (1901)
  3. Review (494)
  4. Editorial (342)
  5. Correspondence (121)
  6. Guidelines (114)
  7. Book Section (99)
  8. Research Letter (95)
  9. Miscellaneous (61)
  10. Conference Paper (33)
  11. Book Whole (2)
Groups
  1. Department of Medicine (2560)
  2. Solid Tumor Oncology Division (1535)
  3. GSK Faculty (1257)
  4. Sloan Kettering Institute Postdocs (1240)
  5. Hematologic Malignancies, Division of (936)
  6. Survivorship Research (930)

More Groups

People
  1. Jorge Reis-Filho (93)
  2. Miguel-Angel Perales (93)
  3. Sergio Giralt (91)
  4. Alexander Drilon (81)
  5. Britta Weigelt (76)
  6. Nadeem Abu-Rustum (71)

More People

Years
  1. 2020 (5599)
Publications
  1. Journal of Clinical Oncology (500)
  2. Blood (212)
  3. Cancer Research (185)
  4. Annals of Oncology (152)
  5. International Journal of Radiation Oncology, Biology, Physics (129)
  6. Laboratory Investigation (116)

More Publications

Publishers
  1. Elsevier Inc. (714)
  2. American Society of Clinical Oncology (548)
  3. Nature Publishing Group (385)
  4. American Association for Cancer Research (357)
  5. Oxford University Press (356)
  6. Springer (342)

More Publishers

Results (5599)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Personalized targeted radioimmunotherapy with anti-CD45 iodine ((131)I) apamistamab [Iomab-B] in patients with active relapsed or refractory acute myeloid leukemia results in successful donor hematopoietic cells engraftment with the timing of engraftment not related to the radiation dose delivered
    Meeting Abstract

    Gyurkocza, B.; Nath, R.; Choe, H.; Seropian, S.; Stiff, P. J.; Abhyankar, S.; Agura, E.; Litzow, M.; Tomlinson, B. K.; Chen, G. L.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • High doses of targeted radiation with anti-CD45 iodine ((131)I) apamistamab [Iomab-B] do not correlate with incidence of mucositis, febrile neutropenia or sepsis in the prospective, randomized phase 3 SIERRA trial for patients with relapsed or refractory acute myeloid leukemia
    Meeting Abstract

    Gyurkocza, B.; Nath, R.; Choe, H.; Seropian, S.; Stiff, P. J.; Abhyankar, S.; Agura, E.; Litzow, M.; Tomlinson, B. K.; Chen, G. L.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Clinical benefit of crenolanib, with or without salvage chemotherapy, in multiply relapsed, FLT3 mutant AML patients after prior treatment with gilteritinib
    Meeting Abstract

    Goldberg, A. D.; Geyer, M. B.; Kell, J.; Di Bona, E.; Pardee, T. S.; Bhave, R.; Grunwald, M. R.; Marconi, G.; Wang, Y. J.; Pathan, A.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Interplay between chromosomal alterations and gene mutations shapes the evolutionary trajectory of clonal hematopoiesis
    Meeting Abstract

    Gao, T.; Ptashkin, R.; Bolton, K. L.; Fong, C.; Spitzer, B.; Menghrajani, K.; Arango Ossa, J. E.; Zhou, Y.; Bernard, E.; Levine, M.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Phase II study of blinatumomab and concurrent oral tyrosine kinase inhibitor therapy as consolidation and maintenance therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia following chemotherapy-sparing induction
    Meeting Abstract

    Geyer, M. B.; King, A. C.; O'Brien, J. C.; Park, J. H.
    Blood (2020)

    Fulltext@MSK | Save
  • CD5-positive marginal zone lymphoma: Clinical characteristics of the MSKCC Cohort, and comparison with the CD5-negative population
    Meeting Abstract

    Ghione, P.; Bantilan, K. S.; Joffe, E.; Lia Palomba, M.; Noy, A.; Matasar, M. J.; Caron, P.; Hamilton, A.; Hamlin, P. A.; Kumar, A.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Clinical characteristics and follow-up post-surgery of women with BIA-ALCL operated at a single institution
    Meeting Abstract

    Ghione, P.; Vorstenbosch, J.; Cordeiro, P. G.; Arcila, M. E.; Moskowitz, A. J.; Owens, C.; Galasso, N.; Nelson, J. A.; Dogan, A.; McCarthy, C. M.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Brentuximab vedotin plus bendamustine for pediatric patients with relapsed/refractory Hodgkin lymphoma: A multi-institution retrospective analysis
    Meeting Abstract

    Forlenza, C. J.; Gulati, N.; Mauguen, A.; Absalon, M. J.; Castellino, S. M.; Franklin, A.; Keller, F. G.; Shukla, N.
    Blood (2020)

    Fulltext@MSK | Save
  • Personalized risk-profiling for acute leukemia patients undergoing haploidentical allogeneic hematopoietic stem cell transplantation: A study on behalf of the Acute Leukemia Working Party of the EBMT
    Meeting Abstract

    Fein, J. A.; Shouval, R.; Labopin, M.; Ciceri, F.; Angelucci, E.; Blaise, D.; Tischer, J.; Arcese, W.; Koc, Y.; Bruno, B.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Germline contributions to clonal hematopoiesis in solid cancer patients
    Meeting Abstract

    Franch-Expósito, S.; Srinivasan, P.; Ptashkin, R.; Bandlamudi, C.; Bolton, K. L.; Gedvilaite, E.; Menghrajani, K.; Mandelker, D.; Comen, E.; Norton, L.; more...
    Blood (2020)

    Fulltext@MSK | Save